Showing results (551-560 of 562) with videos related to

Sort By:
Pageof 57
Contemporary Clinical Trials|December 12, 2023
The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysisLaura M Dember, Jesse Y Hsu, Leah Bernardo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 14, 2025
Chronic Pain Locations, Characteristics, and Associations With Other Symptoms in Adults Receiving Maintenance Hemodialysis: Findings From the HOPE Consortium TrialMichael J Fischer, Jesse Y Hsu, Joanna Walsh, et al.
The Clinical Journal of Pain|December 21, 2006
An interdisciplinary expert consensus statement on assessment of pain in older personsThomas Hadjistavropoulos, Keela Herr, Dennis C Turk, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 24, 2026
Features predicting data exclusion in imaging studies of Alzheimer's diseaseShaney Flores, Jalen Scott, Ruijin Lu, et al.
Research Square|November 24, 2025
The Knight Alzheimer Research Imaging (KARI) dataset: a comprehensive multimodal resource for exploring aging, preclinical, and symptomatic Alzheimer disease pathologyDavid A Hoagey, Nicole S McKay, Nelly Joseph-Mathurin, et al.
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.
JAMA Internal Medicine|January 9, 2025
Pain Coping Skills Training for Patients Receiving Hemodialysis: The HOPE Consortium Randomized Clinical TrialLaura M Dember, Jesse Y Hsu, Rajnish Mehrotra, et al.
Biological Psychiatry|August 9, 2005
Mood disorders in the medically ill: scientific review and recommendationsDwight L Evans, Dennis S Charney, Lydia Lewis, et al.
Neuroimage. Clinical|January 5, 2021
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer diseaseAylin Dincer, Brian A Gordon, Amrita Hari-Raj, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2025
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trialAustin McCullough, Charles D Chen, Brian A Gordon, et al.
Pageof 57